Parallax Volatility Advisers, L.P. Alkermes Plc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$21.94 - $26.24 $583,604 - $697,984	-26,600 Reduced 62.88%	15,700 $410,000
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $930,600 - $1.35 Million	42,300 New	42,300 $945,000
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $3.46 Million - $4.2 Million	-150,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $1.07 Million - $1.6 Million	50,000 Added 50.0%	150,000 $3.49 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $1.88 Million - $2.52 Million	100,000 New	100,000 $2.45 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $19.41 $399,300 - $582,300	-30,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $1.89 Million - $3.08 Million	-145,000 Reduced 82.86%	30,000 $433,000
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $8.35 Million - $9.69 Million	175,000	175,000 $9.58 Million

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.